BBNX
Beta Bionics, Inc.
NASDAQ · Healthcare · Medical - Equipment & Services · US
$19.12
−4.04%Margins
Gross margin
58.3%
EBITDA margin
-60.3%
EBIT margin
-69.8%
Net margin
-61.3%
FCF margin
-51.6%
-28.5%
Return on equity
-25.0%
Return on assets
-31.6%
Return on invested capital
0.40x
Asset turnover
-$55.8M
Cash from operations
$4.01
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026